Tech Company Financing Transactions
Senex Biotechnology Funding Round
On 12/31/2013, Senex Biotechnology announced funding from SCRA.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
715 Sumter St.
Columbia, SC 29208
USA
Columbia, SC 29208
USA
Phone
Website
Email Address
Overview
Senex Biotechnology is a drug discovery company dedicated to becoming the world's leading company that targets a signaling pathway activated by cellular damage and involved in cell senescence (aging).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lawrence Friedhoff
Founder
Igor Roninson
Browse more venture capital transactions:
Prev: 12/31/2013: OutSmart Power Systems venture capital transaction
Next: 12/31/2013: Sustainable Real Estate Solutions venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs